Literature DB >> 33765237

Neurotoxin-Induced Rodent Models of Parkinson's Disease: Benefits and Drawbacks.

Mohamed El-Gamal1,2, Mohamed Salama3,4,5, Lyndsey E Collins-Praino6, Irina Baetu6, Ahmed M Fathalla7, Amira M Soliman7, Wael Mohamed8,9, Ahmed A Moustafa10,11.   

Abstract

Parkinson's disease (PD), the second most common neurodegenerative disorder, is characterized by cardinal motor impairments, including akinesia and tremor, as well as by a host of non-motor symptoms, including both autonomic and cognitive dysfunction. PD is associated with a death of nigral dopaminergic neurons, as well as the pathological spread of Lewy bodies, consisting predominantly of the misfolded protein alpha-synuclein. To date, only symptomatic treatments, such as levodopa, are available, and trials aiming to cure the disease, or at least halt its progression, have not been successful. Wong et al. (2019) suggested that the lack of effective therapy against neurodegeneration in PD might be attributed to the fact that the molecular mechanisms standing behind the dopaminergic neuronal vulnerability are still a major scientific challenge. Understanding these molecular mechanisms is critical for developing effective therapy. Thirty-five years ago, Calne and William Langston (1983) raised the question of whether biological or environmental factors precipitate the development of PD. In spite of great advances in technology and medicine, this question still lacks a clear answer. Only 5-15% of PD cases are attributed to a genetic mutation, with the majority of cases classified as idiopathic, which could be linked to exposure to environmental contaminants. Rodent models play a crucial role in understanding the risk factors and pathogenesis of PD. Additionally, well-validated rodent models are critical for driving the preclinical development of clinically translatable treatment options. In this review, we discuss the mechanisms, similarities and differences, as well as advantages and limitations of different neurotoxin-induced rat models of PD. In the second part of this review, we will discuss the potential future of neurotoxin-induced models of PD. Finally, we will briefly demonstrate the crucial role of gene-environment interactions in PD and discuss fusion or dual PD models. We argue that these models have the potential to significantly further our understanding of PD.

Entities:  

Keywords:  Animal models; Dopamine; Epigenetics; Parkinsonian; Pesticides; Toxins

Year:  2021        PMID: 33765237     DOI: 10.1007/s12640-021-00356-8

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  193 in total

1.  Pesticide exposure and risk for Parkinson's disease.

Authors:  Alberto Ascherio; Honglei Chen; Marc G Weisskopf; Eilis O'Reilly; Marjorie L McCullough; Eugenia E Calle; Michael A Schwarzschild; Michael J Thun
Journal:  Ann Neurol       Date:  2006-08       Impact factor: 10.422

2.  The 6-OHDA mouse model of Parkinson's disease - Terminal striatal lesions provide a superior measure of neuronal loss and replacement than median forebrain bundle lesions.

Authors:  V Bagga; S B Dunnett; R A Fricker
Journal:  Behav Brain Res       Date:  2015-04-02       Impact factor: 3.332

3.  A Nigro-Vagal Pathway Controls Gastric Motility and Is Affected in a Rat Model of Parkinsonism.

Authors:  Laura Anselmi; Luca Toti; Cecilia Bove; Jessica Hampton; R Alberto Travagli
Journal:  Gastroenterology       Date:  2017-09-11       Impact factor: 22.682

Review 4.  Natural plant chemicals: sources of industrial and medicinal materials.

Authors:  M F Balandrin; J A Klocke; E S Wurtele; W H Bollinger
Journal:  Science       Date:  1985-06-07       Impact factor: 47.728

5.  Repeated malathion exposure induces behavioral impairment and AChE activity inhibition in brains of rat pups.

Authors:  Carmine Inês Acker; Ana Cristina Guerra Souza; Simone Pinton; Juliana Trevisan da Rocha; Caroline Amaral Friggi; Renato Zanella; Cristina Wayne Nogueira
Journal:  Ecotoxicol Environ Saf       Date:  2011-08-19       Impact factor: 6.291

6.  Consequences of developmental exposure to concentrated ambient ultrafine particle air pollution combined with the adult paraquat and maneb model of the Parkinson's disease phenotype in male mice.

Authors:  Joshua L Allen; Xiufang Liu; Douglas Weston; Katherine Conrad; Günter Oberdörster; Deborah A Cory-Slechta
Journal:  Neurotoxicology       Date:  2014-01-30       Impact factor: 4.294

7.  Projected numbers of people with movement disorders in the years 2030 and 2050.

Authors:  Jan-Philipp Bach; Uta Ziegler; Günther Deuschl; Richard Dodel; Gabriele Doblhammer-Reiter
Journal:  Mov Disord       Date:  2011-10       Impact factor: 10.338

8.  Behavioral effects and ChE measures after acute and repeated administration of malathion in rats.

Authors:  Fabrício L Assini; Kênia D Zanette; Patrícia S Brocardo; Pablo Pandolfo; Ana Lúcia S Rodrigues; Reinaldo N Takahashi
Journal:  Environ Toxicol Pharmacol       Date:  2005-07-14       Impact factor: 4.860

9.  Antidepressant-like effect of diphenyl diselenide on rats exposed to malathion: involvement of Na+K+ ATPase activity.

Authors:  Carmine I Acker; Cristiane Luchese; Marina Prigol; Cristina W Nogueira
Journal:  Neurosci Lett       Date:  2009-03-27       Impact factor: 3.046

Review 10.  Parkinson's disease and pesticide exposure--a new assessment.

Authors:  Minako Takamiya Allen; Leonard S Levy
Journal:  Crit Rev Toxicol       Date:  2013-07       Impact factor: 5.635

View more
  6 in total

Review 1.  Traumatic brain injury and the development of parkinsonism: Understanding pathophysiology, animal models, and therapeutic targets.

Authors:  Smrithi Padmakumar; Praveen Kulkarni; Craig F Ferris; Benjamin S Bleier; Mansoor M Amiji
Journal:  Biomed Pharmacother       Date:  2022-03-12       Impact factor: 7.419

2.  Nanoemulsion Improves the Neuroprotective Effects of Curcumin in an Experimental Model of Parkinson's Disease.

Authors:  Osmar Vieira Ramires Júnior; Barbara da Silva Alves; Paula Alice Bezerra Barros; Jamile Lima Rodrigues; Shana Pires Ferreira; Linda Karolynne Seregni Monteiro; Gabriela de Moraes Soares Araújo; Sara Silva Fernandes; Gustavo Richter Vaz; Cristiana Lima Dora; Mariana Appel Hort
Journal:  Neurotox Res       Date:  2021-04-16       Impact factor: 3.978

Review 3.  Current approaches to characterize micro- and macroscale circuit mechanisms of Parkinson's disease in rodent models.

Authors:  Yangfan Peng; Nina Schöneberg; Maria Soledad Esposito; Jörg R P Geiger; Andrew Sharott; Philip Tovote
Journal:  Exp Neurol       Date:  2022-02-09       Impact factor: 5.620

Review 4.  Experimental Models of Cognitive Impairment for Use in Parkinson's Disease Research: The Distance Between Reality and Ideal.

Authors:  Yaohua Fan; Jiajun Han; Lijun Zhao; Chunxiao Wu; Peipei Wu; Zifeng Huang; Xiaoqian Hao; YiChun Ji; Dongfeng Chen; Meiling Zhu
Journal:  Front Aging Neurosci       Date:  2021-11-29       Impact factor: 5.750

5.  An Investigation of the Neurotoxic Effects of Malathion, Chlorpyrifos, and Paraquat to Different Brain Regions.

Authors:  Ekramy Elmorsy; Ayat Al-Ghafari; Huda Al Doghaither; Mohamed Salama; Wayne G Carter
Journal:  Brain Sci       Date:  2022-07-24

Review 6.  The Neuroprotective Effects of Cannabis-Derived Phytocannabinoids and Resveratrol in Parkinson's Disease: A Systematic Literature Review of Pre-Clinical Studies.

Authors:  Samay Prakash; Wayne G Carter
Journal:  Brain Sci       Date:  2021-11-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.